Neoplasia

Papers
(The H4-Index of Neoplasia is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A79
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene76
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis74
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]68
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]67
Identification of molecularly targeted therapy-induced immunopeptidome in diffuse midline glioma (DMG)56
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway55
DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC55
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma54
ARID1A loss sensitizes colorectal cancer cells to floxuridine49
Epitranscriptomic mechanisms of androgen signalling and prostate cancer49
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma46
The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for hereditary pancreatic diseases (EUROPAC-PLUS)45
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD44
BPGM as an intrinsic brake to constrain metastasis through phospho-epigenetic-mediated carnitine biosynthesis suppression43
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling43
Mutational signatures and their association with survival and gene expression in urological carcinomas43
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism41
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series40
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine37
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer37
CCAAT‐enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia35
Tumor-Infiltrating Immune Cells in Colorectal Cancer35
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice34
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy33
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]33
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations32
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors32
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations32
A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate31
Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications30
PDGFRα governs multiple cellular signals and plays a protective role in tumor progression30
Advanced progress of spatial metabolomics in head and neck cancer research30
Lactate promoted cisplatin resistance in NSCLC by modulating the m6A modification-mediated FOXO3/MAGI1-IT1/miR-664b-3p/IL-6R axis30
0.30463409423828